Clinical trial NCT06432400: Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders
Official title: Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders Followed up in the Medical and Psychological Centre: Multicentre Descriptive Study
Study type: INTERVENTIONAL
Overall status: WITHDRAWN
Phase: NA
Conditions: Trauma
Keywords: Post Traumatic Stress Disorder
Complex post traumatic stress disorder
Medical and Psychological Centre
Lead sponsor: Hôpital NOVO
Sponsor class: OTHER
First posted: 2024-05-29
Enrollment: 0
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: OTHER

Brief summary: The aim of this study is to show that early identification of PTSD and CPTSD would increase recognition of these disorders and facilitate diagnosis, referral and recovery.

Detailed description: Between 61% and 81% of men and 51% to 74% of women are exposed to a traumatic event in their lifetime. These events may be brief and discrete, prolonged and/or recurrent, and may be direct or indirect. Direct or indirect exposure to traumatic events can lead to serious negative psychological consequences, including post-traumatic stress disorder (PTSD) and complex post-traumatic stress disorder (CPTSD). People exposed to complex traumatic events are at risk not only of suffering from PTSD or Complex PTSD, but also from other mental health co-morbidities, such as substance use disorders (drugs, alcohol, benzodiazepine misuse) , often associated with the repetition of situations of interpersonal violence from which it is difficult, if not impossible, to escape.

Caring for people suffering from psychological trauma is a major public health issue. However, there are no good clinical practice guidelines for diagnosis, assessment and treatment, which would enable good practice to be standardised and disseminated. The prevention, detection, early support and appropriate guidance of people suffering from post-traumatic sequelae promote their recovery and improve their quality of life. The World Health Organization (WHO) refers to this as psychological distress, and points out that if it is not properly identified or accompanied, it can tip a person into illness or increase social difficulties. When it is temporary and follows a stressful event, it is considered a normal adaptive reaction. On the other hand, when it becomes intense and persistent, it may be an indicator of a psychological disorder. The public health challenge associated with PTSD is to better recognise, diagnose and treat it, as it can have serious consequences for the quality of life, social functioning and suicide risk of those affected.

The aim of this study is to show that early identification of PTSD and CPTSD would increase recognition of these disorders and facilitate diagnosis, referral and recovery. It would also make it possible to provide individualised support for patients and improve their quality of life.

Eligibility criteria: Inclusion Criteria :

* Patient aged 18 or over
* Patient followed up at the adult Medical and Psychological Centre in the centres taking part in the study
* Patient suffering from disorders related to the use of alcohol, cannabis, opiates, inhalants, sedatives, hypnotics, anxiolytics, stimulants, hallucinogens (all of these disorders will have been diagnosed by a doctor before or during follow-up according to DSM 5 criteria).
* Patient aware of their substance use disorders
* Patient informed and did not object to participating in the study

Exclusion Criteria :

* Patient previously diagnosed with PTSD or CPTSD
* Patient agitated and/or aggressive
* Patient under guardianship/curators
* Patient who do not speak or understand French

Primary outcomes:
measure: Assessment of the proportion of Post-Traumatic Stress Disorder (PTSD) in patients with substance use disorders
timeFrame: At the end of the study, an average of 12 month
Secondary outcomes:
measure: Distinguishing between the prevalence of Post-Traumatic Stress Disorder (PTSD) and Complex Post-Traumatic Stress Disorder (CPTSD)
timeFrame: At the end of the study, an average of 12 month
measure: Identification of risk factors by comparing demographic data of PTSD versus CPTSD patients
timeFrame: At the end of the study, an average of 12 month
measure: Identification of the pathologies most associated with PTSD and CPTSD
timeFrame: At the end of the study, an average of 12 month
measure: Comparison of the time between management and identification of patients with PTSD versus CPTSD
timeFrame: At the end of the study, an average of 12 month
Other outcomes:
Locations:
city: Beaumont-sur-Oise
country: France
facility: Medical and Psychological Centre - Novo Hospital - Site Beaumont-sur-Oise
city: Clermont
country: France
facility: Medical and Psychological Centre - Isarien Hospital Centre
Study officials:
affiliation: Isarien Hospital Centre
name: Déborah DELABY
role: PRINCIPAL_INVESTIGATOR
References: